The 1990s marked a pivotal era in the development of gene therapy, with groundbreaking advancements and significant challenges shaping the landscape of regenerative medicine. Gene therapy, a revolutionary approach aimed at addressing genetic disorders at their root cause, heralded a new dawn in personalized healthcare.
One of the earliest milestones in gene therapy occurred in 1990 when researchers at The National Institutes of Health conducted one of the first gene therapy treatments on two young girls diagnosed with severe combined immunodeficiency (SCID). This rare and life-threatening disorder, caused by a genetic mutation, compromises the immune system, leaving patients vulnerable to infections and health complications.
